Back to Search Start Over

Cost-effectiveness of consolidation durvalumab after chemo-radiotherapy in stage III non-small-cell lung cancer: A cost-effective change.

Authors :
Giuliani J
Infante MV
Micheletto C
Bonetti A
Source :
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners [J Oncol Pharm Pract] 2022 Mar; Vol. 28 (2), pp. 438-441. Date of Electronic Publication: 2021 Oct 05.
Publication Year :
2022

Details

Language :
English
ISSN :
1477-092X
Volume :
28
Issue :
2
Database :
MEDLINE
Journal :
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
Publication Type :
Academic Journal
Accession number :
34609930
Full Text :
https://doi.org/10.1177/10781552211045362